Benzinga's Top Downgrades

Analysts at Nomura downgraded Intelsat S.A. I from Buy to Neutral. The price target for Intelsat has been lowered from $26.00 to $13.00. Intelsat's shares closed at $13.19 on Friday. Analysts at JP Morgan downgraded Century Communities, Inc. CCS from Overweight to Neutral. The price target for Century Communities has been lowered from $22.00 to $19.00. Century Communities' shares closed at $18.38 on Friday. Analysts at Piper Jaffray downgraded Salix Pharmaceuticals Ltd. SLXP from Overweight to Neutral. The price target for Salix Pharmaceuticals has been lowered from $160.00 to $158.00. Salix Pharmaceuticals' shares closed at $157.85 on Friday. Analysts at Bank of America downgraded Quest Diagnostics Inc. DGX from Neutral to Underperform. Quest Diagnostics' shares closed at $71.77 on Friday